Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
903.90
6.85 (0.76%)
< Home < Back

Natco Pharma submits copy of presentation made to analysts

Date: 03-06-2016

Natco Pharma has submitted a copy of the presentation made to analysts /Investors on Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2016.

The above information is a part of company’s filings submitted to BSE.